R&D | Ophthalmology Innovation Source

Translatum Medicus

Presenter: Shelley Boyd, MD, FRCSC Shelley Boyd, MD, FRCSC, is an Ophthalmologist specializing in diseases of the retina and founding President & CSO of Translatum Medicus Inc(TMi). She trained at the University of Toronto, with fellowships at Moorfields Eye Hospital, UK and the Scripps Research Institute, California. View Full Profile

Acucela

Participant: Ryo Kubota, MD, PhD Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases affecting millions of individuals worldwide. View Full Profile

Alcon – Google Innovation: Visions of Ophthalmology in 2020

Participants: William J. Link, PhD Prior to Versant, Bill was a general partner at Brentwood Venture Capital. He founded, and served as chairman and CEO of Chiron Vision. Chiron Vision was sold to Bausch and Lomb in 1997. View Full Profile Laurent Attias Laurent Attias is currently Senior Vice President, Head of Strategy, BD&L and…

Masters of the Universe

Participants: Jim Mazzo James V. Mazzo is Global President for Carl Zeiss Meditec’s Strategic Business Unit Ophthalmic Devices, which includes Ophthalmic Diagnostics, Surgical Ophthalmology and Refractive Lasers. View Full Profile Jeff George Jeff was appointed to lead Alcon in May 2014. As the global leader in eye care, Alcon provides innovative products that enhance quality…

Saunders Speaks to Allergan’s Innovative Culture

Prior to the announcement of the Pfizer-Allergan combination, Allergan CEO and President Brent Saunders spoke with OISTV about how the pharma industry finds and foster innovation, particularly in ophthalmology. Under Saunders, Allergan works hard to “support” rather than “assimilate” new technologies like Oculeve’s neurostimulation-based treatment for Dry Eye. As President and COO of the new…

Transcend’s Move Toward PMA

Well, the MIGs market could get a little more crowded. This week, Transcend Medical announced it had submitted the final module of its PMA application for the CyPass Micro-Stent, an implant designed to reduce intraocular pressure (IOP) in patients with primary open-angle glaucoma. FDA approval, which likely won’t come until next year at the earlier,…

Legislation Would Restore NEI/NIH Funding

The 21st Century Cures Act – which is receiving uncharacteristic bipartisan support – could restore many of the Ophthalmology-oriented research grant programs cut in recent years. By a 51-0 vote in May, the House Energy and Commerce Committee endorsed the increase of overall National Institutes of Health funding by $1.5 billion a year over each…

A Discussion Of Allergan’s Legacy And Future In Medtech Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 045″] Hear from Allergan’s Past and Future: Highlights of interviews with Brent Saunders and Gavin Herbert. Podcast Guest Brent Saunders Brent Saunders has served as CEO and President of Allergan, formerly Actavis, since July 1, 2014. Previously, Mr. Saunders served as CEO and President of Forest Laboratories from 2013 to 2014.…

Here is How Big Companies Innovate

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 044″] Leaders of Alcon, AMO, Valeant and Zeiss Discuss the Role of Innovation in their Success. Podcast Transcript Tom Salemi: Hi, welcome back to the OIS Podcast. This is Tom Salemi, your host. Thank you so much for joining us today. If you tuned in last week, you heard from J.…

Ophthalmology Lifetime Innovator Award

OIS@ASCRS - 2015 Award Winner - Richard Lindstrom, MD

Richard L. Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants Participant: Richard Lindstrom, MD Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery. View Full Profile

Hear How Valeant Innovates, Invests & Acquires

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 043″] Valeant CEO J. Michael Pearson tells OIS attendees how the controversial company finds new technologies. Podcast Guest J. Michael Pearson Mr. Pearson has been the CEO and serving on the Board since September 2010 and the Chairman of the Board since March 2011. From February 2008 to September 2010, he…

Spotlight on MIGS

Participants: Eric Donnenfeld, MD Eric Donnenfeld, MD is a founding partner of Ophthalmic Consultants of Long Island, Professor of Ophthalmology NYU and a Trustee at Dartmouth Medical School. View Full Profile Richard Lewis, MD Richard A. Lewis, M.D. is the former director of glaucoma at the University of California, Davis before co-founding Sacramento Eye Consultants.…